aTyr Pharma, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR

aTyr Pharma, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – ATYR GlobeNewswire November 03, 2025 LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations […]

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL(R) System as a Standard of Care in Acute Wound Treatment

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL(R) System as a Standard of Care in Acute Wound Treatment Global evidence and real-world data demonstrate the clinical, operational, and economic impact of AVITA Medical's RECELL System across wound types and patient populations GlobeNewswire November 03, 2025 VALENCIA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE)

Brag House Holdings, Inc., to Create New Financial Powerhouse Anchored by Payments, Asset Management, and RWA Strategy with House of Doge – The Official Corporate Arm of the Dogecoin Foundation

Brag House Holdings, Inc., to Create New Financial Powerhouse Anchored by Payments, Asset Management, and RWA Strategy with House of Doge – The Official Corporate Arm of the Dogecoin Foundation Combined entity poised to reshape digital payments, asset management, RWA tokenization, and digital media by applying Brag House's proven model to a global stage. GlobeNewswire

LiveOne (Nasdaq: LVO) Accelerates Revenue Growth with Intuizi AI, Driving Tesla Subscriber Conversions

LiveOne (Nasdaq: LVO) Accelerates Revenue Growth with Intuizi AI, Driving Tesla Subscriber Conversions GlobeNewswire November 03, 2025 Key Insights: Tesla ad-supported subscribers have grown to 1M+ over the last year 60% ARPU increase to over $5 31%+ increase in subscription engagement since launch 22%+ increase in Plus/Premium conversions since launch LOS ANGELES, Nov. 03, 2025

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation GlobeNewswire November 03, 2025 120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully ConcludedDSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns SEATTLE and VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV),

IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results

IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance GlobeNewswire November 03, 2025 Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in 2024. Reports record GAAP

Alico Inc. partners with Florida Department of Transportation to construct wildlife underpass along State Road 82

Alico Inc. partners with Florida Department of Transportation to construct wildlife underpass along State Road 82 GlobeNewswire November 03, 2025 FORT MYERS, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) — Alico Inc., (“Alico” or the “Company”) (Nasdaq: ALCO) a Southwest Florida-based agribusiness and land management company with over 125 years of experience, has announced a strategic

BTCS to Participate in Upcoming November Conferences

BTCS to Participate in Upcoming November Conferences GlobeNewswire November 03, 2025 WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that management will be participating in the following November 2025 investor conferences. Blockchain FuturistDates: November 5-6,

CytoDyn Secures $30 Million Commitment from Yorkville Advisors

CytoDyn Secures $30 Million Commitment from Yorkville Advisors GlobeNewswire November 03, 2025 VANCOUVER, Washington, Nov. 03, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including triple-negative breast cancer (TNBC) and

Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights

Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights GlobeNewswire November 03, 2025 TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in

Scroll to Top